Solstice Oncology
Latest round
- Series A
Last raised
- Feb 2026
Total raised
- $121M
Investors
- 3
About Solstice Oncology
Founded in 2026 and based in Massachusetts, Solstice Oncology is a clinical-stage immuno-oncology company developing cancer therapies for use before surgery for targeting colon cancer and other early-stage solid tumors.
Who invested in Solstice Oncology
3 investors across 1 round
See all investors in Solstice Oncology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Feb 20, 2026
Amount
$121M
Investors
Questions about Solstice Oncology
Who invested in Solstice Oncology?
Solstice Oncology has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Solstice Oncology raised?
Solstice Oncology has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Solstice Oncology last raise money?
Solstice Oncology's most recent round on record is a Series A, in Feb 2026.
What does Solstice Oncology do?
Founded in 2026 and based in Massachusetts, Solstice Oncology is a clinical-stage immuno-oncology company developing cancer therapies for use before surgery for targeting colon cancer and other early-stage solid tumors.
Where is Solstice Oncology headquartered?
Solstice Oncology is headquartered in Boston, US.
Which VCs invest in companies like Solstice Oncology?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Solstice Oncology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Solstice Oncology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.